Advertisement

Topics

Helmedix Pty Ltd Company Profile

03:44 EDT 23rd October 2017 | BioPortfolio

Helmedix is developing new therapies for autoimmune diseases. The company has identified peptides derived from helminthic worms that have immune-modulating properties. These peptides are being explored as novel approach to treating autoimmune diseases such as rheumatoid arthritis, colitis, psoriasis and multiple sclerosis. Helmedix is currently focused on a program to progress lead optimisation and pre-clinical development of the helminth-derived peptides. The Helmedix technology originated from the team of Dr Sheila Donnelly at the i3 institute in Sydney.

Location

Sydney
Australia


News Articles [0 Results]

None

Drugs and Medications [0 Results]

None

PubMed Articles [0 Results]

None

Clinical Trials [0 Results]

None

Companies [1 Associated Companies listed on BioPortfolio]

Helmedix Pty Ltd

Helmedix is developing new therapies for autoimmune diseases. The company has identified peptides derived from helminthic worms that have immune-modulating properties. These peptides are being explo...

More Information about "Helmedix Pty Ltd" on BioPortfolio

We have published hundreds of Helmedix Pty Ltd news stories on BioPortfolio along with dozens of Helmedix Pty Ltd Clinical Trials and PubMed Articles about Helmedix Pty Ltd for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Helmedix Pty Ltd Companies in our database. You can also find out about relevant Helmedix Pty Ltd Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topic

Autoimmune Disorders
Autoimmune disorders are conditions that occurs when the immune system mistakenly attacks and destroys healthy body tissue. There are more than 80 different types of autoimmune disorders. Normally the immune system's white blood cells help protect ...


Corporate Database Quicklinks



Searches Linking to this Company Record